A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 51
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AnxA5
Long Form : Annexin A5
No. Year Title Co-occurring Abbreviation
2020 Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment. PS, TME
2020 Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. NAFLD, NASH, PKM2
2019 Absence of Distinct Immunohistochemical Distribution of Annexin A5, C3b, C4d, and C5b-9 in Placentas From Patients With Antiphospholipid Antibodies, Preeclampsia, and Systemic Lupus Erythematosus. APLA, APLS, PEC, SLE
2019 Loss of Annexin A5 expression attenuates the lipopolysaccharide-induced inflammatory response of rat alveolar macrophages. ALI, AMs, IkappaB, LPS, mRNAs, NF-kappaB, Nrf2, qRT-PCR, TNF-alpha
2019 The association between genetic polymorphisms of the interleukin-10, tumor necrosis factor-alpha, and annexin A5 gene loci and restenosis after percutaneous coronary angioplasty and stenting. hs-CRP, IL-10, ISR, NISR, TNF-alpha
2018 Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response. IS, LV, MI-R
2017 Annexin A5 reduces early plaque formation in ApoE -/- mice. ---
2017 Annexin-A5 organized in 2D-network at the plasmalemma eases human trophoblast fusion. ---
2017 Buserelin alleviates chloride transport defect in human cystic fibrosis nasal epithelial cells. CF, CFTR
10  2017 The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies. TEG, TF
11  2016 Annexin A5 in treated hypertensive patients and its association with target organ damage. TOD
12  2016 Membrane repair of human skeletal muscle cells requires Annexin-A5. LGMD2B
13  2015 Annexin-A5 promotes membrane resealing in human trophoblasts. ---
14  2015 Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review. PLs
15  2015 Review: Annexin-A5 and cell membrane repair. ---
16  2014 A dual-labeled Annexin A5 is not suited for SPECT imaging of brain cell death in experimental murine stroke. MCAO, PS, SPECT
17  2014 AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(-/-) mice. ---
18  2014 Comparison of methods for evaluating radiolabelled Annexin A5 uptake in pre-clinical PET oncological studies. DVRs, EPR, SUVs
19  2014 Impaired osteoblast differentiation in annexin A2- and -A5-deficient cells. ANXA2
20  2014 Improvement of chloride transport defect by gonadotropin-releasing hormone (GnRH) in cystic fibrosis epithelial cells. CF, ER, GnRH, GnRHR
21  2014 XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation. PEG
22  2013 An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. ---
23  2013 Circulating annexin A5 levels after atrial switch for transposition of the great arteries: relationship with ventricular deformation and geometry. EI, GLS, MMP-1, PIIINP, TIMP-1, TNF
24  2013 Differential expression of peroxiredoxin 6, annexin A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1 in testis of rat fetuses after maternal exposure to di-n-butyl phthalate. DBP, Prdx6, UchL1
25  2013 In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis. ---
26  2012 Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity. LPS, TNF-alpha
27  2012 Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice. PCI, PS
28  2012 Depletion of annexin A5, annexin A6, and collagen X causes no gross changes in matrix vesicle-mediated mineralization, but lack of collagen X affects hematopoiesis and the Th1/Th2 response. AnxA6
29  2012 Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death. PET
30  2012 Transcellular distribution heterogeneity of Annexin A5 represents a protective response to lupus-related thrombophilia: a pilot Proteomics-based study. PBMCs, SLE
31  2011 Annexin-A5 assembled into two-dimensional arrays promotes cell membrane repair. ---
32  2011 Effect of Mg2+ versus Ca2+ on the behavior of annexin A5 in a membrane-bound state. BAM, MD, PM-IRRAS, QCM-D
33  2010 Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice. APOE, l-NAME, MIP-1beta
34  2010 Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5. CRT, HF, LV, LVEF
35  2010 Determination of molecular groups involved in the interaction of annexin A5 with lipid membrane models at the air-water interface. BAM, PM-IRRAS
36  2010 Effect of Annexin A5 on CFTR: regulated traffic or scaffolding? CFTR, PKC
37  2010 The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. aPL
38  2009 Annexin-A6 presents two modes of association with phospholipid membranes. A combined QCM-D, AFM and cryo-TEM study. AFM, AnxA6, QCM-D, TEM
39  2009 AnnexinA5 renders dead tumor cells immunogenic--implications for multimodal cancer therapies. ITC, PS, stem
40  2009 Beta2-glycoprotein I and annexin A5 phospholipid interactions: artificial and cell membranes. beta2GPI
41  2009 Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. APS, HCQ, PLBs
42  2008 Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome. APS
43  2008 The immune reaction against allogeneic necrotic cells is reduced in Annexin A5 knock out mice whose macrophages display an anti-inflammatory phenotype. KO, PS
44  2007 Factor Xa-driven thrombin generation in plasma: dependency on the aminophospholipid density of membranes and inhibition by phospholipid-binding proteins. maxR, PFP, PS
45  2007 Kinetic analysis of mineral formation during in vitro modeling of matrix vesicle mineralization: effect of annexin A5, phosphatidylserine, and type II collagen. ACP, CPLX, MVs, PS
46  2007 Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction. HHD, LVH
47  2006 Analysis of circulating annexin A5 parameters during pregnancy: absence of differences between women with recurrent spontaneous pregnancy losses and controls. RSPL
48  2006 Annexin A5 levels in midtrimester amniotic fluid: association with intrauterine growth restriction. ELISA, IUGR
49  2006 Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. aPL, beta2GPI, LAC
50  2004 Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. ALP, ANXA1, ANXA2, DPP-IV
51  2003 Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5. B-AnxA5, I-AnxA5